Top compounds associated with response to C22orf31


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.05
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.05
mRNA Gemcitabine gCSI pan-cancer AAC -0.1 0.05
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.063 0.06
mRNA Topotecan CTRPv2 pan-cancer AAC 0.061 0.06
mRNA GSK-J4 CTRPv2 pan-cancer AAC 0.19 0.06
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.059 0.06
mRNA shikonin GDSC1000 pan-cancer AAC -0.065 0.06
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.062 0.06
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.065 0.06
Download CSV